---
title: "SPAC Apogee Acquisition lowers units offered by 40% ahead of $150 million IPO"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281379497.md"
description: "Apogee Acquisition, a SPAC focused on advanced technologies, has reduced its IPO size by 40%, now aiming to raise $150 million by offering 15 million units at $10 each. Previously, it planned to offer 25 million units. Each unit includes one share of common stock, a warrant, and a right to receive a fraction of an ordinary share upon a business combination. Led by CEO Jeffrey Smith, the company targets technology firms across various sectors and plans to list on Nasdaq as AACPU, with Arc Group Securities as the bookrunner."
datetime: "2026-04-01T13:37:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281379497.md)
  - [en](https://longbridge.com/en/news/281379497.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281379497.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/281379497.md) | [繁體中文](https://longbridge.com/zh-HK/news/281379497.md)


# SPAC Apogee Acquisition lowers units offered by 40% ahead of $150 million IPO

Apogee Acquisition, a blank check company targeting advanced technologies, lowered the proposed deal size for its upcoming IPO on Wednesday.

The Cheyenne, WY-based company now plans to raise $150 million by offering 15 million units at $10. The company had previously filed to offer 25 million units at the same price. Each unit still consists of one share of common stock, one warrant exercisable at $11.50, and one right to receive one-fifth of one ordinary share upon the consummation of an initial business combination. At the midpoint of the revised deal size, Apogee Acquisition will raise -40% less in proceeds than previously anticipated.

Apogee Acquisition is led by **CEO and Chairman Jeffrey Smith**, who is the managing member of Apogee Capital Partners, Apogee Strategic Ventures, and Apogee Venture Fund. He is joined by **CFO Ian Rhodes**, the CFO of Renatus Tactical Acquisition I (Nasdaq: RTACU), and the Interim CFO of TNF Pharmaceuticals.

The SPAC intends to target companies developing, integrating, or enabling advanced technologies across both physical and digital domains, including opportunities in software, hardware, compute infrastructure, engineered materials, intelligent systems, automation, specialized components, energy and power technologies, and other technology-driven platforms that support mission-critical functions across modern markets.

Apogee Acquisition was founded in 2025. It plans to list on the Nasdaq under the symbol AACPU. Arc Group Securities is the sole bookrunner on the deal.

### Related Stocks

- [Apogee Acquisition - Unit (AACPU.US)](https://longbridge.com/en/quote/AACPU.US.md)

## Related News & Research

- [A SPAC III Acquisition made PFIC annual statement available for 2025, reports per-share ordinary earnings](https://longbridge.com/en/news/281081330.md)
- [Michael Klein's SPAC Churchill Capital XII files for a $300 million IPO](https://longbridge.com/en/news/281578818.md)
- [ZAWYA: The CMA approves the regulatory framework for offering Special Purpose Acquisition Companies in the parallel market](https://longbridge.com/en/news/281555930.md)
- [Inflection Point Acquisition V Increases Sponsor Promissory Note to $800,000 for Working Capital](https://longbridge.com/en/news/281660715.md)
- [This crypto stock plummets in US trading debut. Can it break the SPAC curse?](https://longbridge.com/en/news/281412771.md)